1-2 of 2
José Rodriguez
Close
Sort by
Journal Articles

Final Results of a Multicenter Phase II Trial with Bendamustine and Rituximab As First Line Treatment for Patients with MALT Lymphoma (MALT-2008–01)

Antonio Salar, MD, Eva Domingo-Domenech, MD, Carlos Panizo, Concepción Nicolás, MD, Joan Bargay, Ana Muntanola, MD, Miguel Canales, Jose Luis Bello, MD, juan Manuel Sancho, Sr., MD, Jose Francisco Tomas, MD, María José Rodriguez, MD, Francisco-Javier Penalver, Luis Palomera, MD, Carlos Grande, José J Sánchez-Blanco, MD, Reyes Arranz, MD, Eulogio Conde, Dolores Caballero, MD, Carlos Montalban
Journal: Blood
Blood (2012) 120 (21): 3691.
https://doi.org/10.1182/blood.V120.21.3691.3691
Published: 2012
Journal Articles

Treatment Stratification According to Early Response to Mega-CHOP, Based on CT and Gallium 67 Scan (G 67 S) with or without IFE Salvage Therapy Followed by Peripheral Autologous Stem Cell Transplant (PBSCT) in Patient with Poor Prognosis Aggressive Lymphoma. A Preliminary Report from a Prospective GEL/TAMO Trial.

Eulogio Conde, MD, Reyes Arranz, José Rodriguez, María L. Gutierrez, Carlos Grande, Marco Gandarillas, Carmen Albo, José L. Bello, Sebastián Garzón, Miguel T. Hernández, José A. García-Vela, Pascual Fernández, María L. Amigo, Dolores Caballero
Journal: Blood
Blood (2005) 106 (11): 3335.
https://doi.org/10.1182/blood.V106.11.3335.3335
Published: 2005